THE AMERICAN SOCIETY FOR CLINICAL INVESTIGATION INC (EIN 520847477) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1908

Legal Domicile

Principal Officer

JOHN HAWLEY

Phone

7342226050

Tax Period

2023-01-01 to 2023-12-31

THE AMERICAN SOCIETY FOR CLINICAL INVESTIGATION INC, founded in 1908, is a community nonprofit in the Unknown sector that reported $5.6M in total revenue in fiscal year 2023. Revenue grew 15% year-over-year, indicating healthy expansion. Net assets of $13.3M represent 28 months of operating reserves.

Mission

PUBLICATION OF RESEARCH JOURNALS AND DISSEMINATION OF RELATED INFORMATION.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $118,140

Program Service Revenue $5,041,284

Investment Income $266,234

Other Revenue $204,377

TOTAL REVENUE $5,630,035

Expense Breakdown

Grants Paid $106,500

Salaries & Benefits $4,108,166

Fundraising Expenses $0

Program Expenses $5,313,347

Other Expenses $1,958,430

TOTAL EXPENSES $6,173,096

Year-over-Year Comparison

	2023	2022	Change
Revenue	$5,630,035	$4,899,750	+0.1%
Expenses	$6,173,096	$5,815,187	+0.1%
Net Income	$-543,061	$-915,437	-0.4%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✓ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✓ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$847,268

Total Directors

$100,000

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ELIZABETH M MCNALLY MD PHD	EDITOR, JCI	20.00	Officer Director	$50,000	$0	$50,000
KATHLEEN L COLLINS	EDITOR, JCI INSIGHT	20.00	Officer Director	$50,000	$0	$50,000
SOHAIL F TAVAZOIE MD PHD	IMMEDIATE PAST PRESIDENT	5.00	Officer Director	$0	$0	$0
BENJAMIN HUMPHREYS MD PHD	PRESIDENT	5.00	Officer Director	$0	$0	$0
ANNA GREKA MDPHD	PRESIDENT-ELECT	2.00	Officer Director	$0	$0	$0
PRISCILLA Y HSUE M D	VICE PRESIDENT	2.00	Officer Director	$0	$0	$0
VIJAY G SANKARAN MD PHD	COUNCILOR	1.00	Director	$0	$0	$0
HEIDI H KONG MD	COUNCILOR	1.00	Director	$0	$0	$0
SUSAN CHENG MD MMSC MPH	COUNCILOR	1.00	Director	$0	$0	$0
GOUTHAM NARLA MD PHD	COUNCILOR	1.00	Director	$0	$0	$0
ELIZABETH K SPELIOTES MD PHD MPH	SECRETARY-TREASURER	1.00	Officer Director	$0	$0	$0
JULIE ANNE BASTARACHE MD	COUNCILOR	1.00	Director	$0	$0	$0
RAJAN JAIN MD	COUNCILOR	1.00	Director	$0	$0	$0
KAREN GUTH	MANAGING DIRECTOR	45.00	Officer	$311,151	$61,568	$372,719
JOHN HAWLEY	EXECUTIVE DIRECTOR	45.00	Officer	$327,057	$47,492	$374,549
SARAH C JACKSON	EXECUTIVE EDITOR	40.00	Highest	$131,897	$46,160	$178,057
MAYA HOPTMAN	SENIOR COPY EDITOR	40.00	Highest	$108,666	$29,437	$138,103

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$5,630,035	$6,173,096	$14,169,077	$-543,061
2022	$4,899,750	$5,815,187	$13,512,348	$-915,437
2021	$6,053,976	$5,268,904	$15,941,863	$785,072
2020	$6,072,230	$4,939,934	$15,044,697	$1,132,296
2019	$5,549,378	$4,919,429	$13,171,046	$629,949
2018	$4,930,311	$4,539,944	$11,353,420	$390,367

THE AMERICAN SOCIETY FOR CLINICAL INVESTIGATION INC